Cargando…

Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles

To investigate the impact of the surface functionalization of mesoporous silica nanoparticle (MSN) carriers in the physical state, molecular mobility and the release of Fenofibrate (FNB) MSNs with ordered cylindrical pores were prepared. The surface of the MSNs was modified with either (3-aminopropy...

Descripción completa

Detalles Bibliográficos
Autores principales: Figari, Giorgia, Gonçalves, José L. M., Diogo, Hermínio P., Dionísio, Madalena, Farinha, José Paulo, Viciosa, María Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301214/
https://www.ncbi.nlm.nih.gov/pubmed/37376073
http://dx.doi.org/10.3390/pharmaceutics15061624
_version_ 1785064759282892800
author Figari, Giorgia
Gonçalves, José L. M.
Diogo, Hermínio P.
Dionísio, Madalena
Farinha, José Paulo
Viciosa, María Teresa
author_facet Figari, Giorgia
Gonçalves, José L. M.
Diogo, Hermínio P.
Dionísio, Madalena
Farinha, José Paulo
Viciosa, María Teresa
author_sort Figari, Giorgia
collection PubMed
description To investigate the impact of the surface functionalization of mesoporous silica nanoparticle (MSN) carriers in the physical state, molecular mobility and the release of Fenofibrate (FNB) MSNs with ordered cylindrical pores were prepared. The surface of the MSNs was modified with either (3-aminopropyl) triethoxysilane (APTES) or trimethoxy(phenyl)silane (TMPS), and the density of the grafted functional groups was quantified via (1)H-NMR. The incorporation in the ~3 nm pores of the MSNs promoted FNB amorphization, as evidenced via FTIR, DSC and dielectric analysis, showing no tendency to undergo recrystallization in opposition to the neat drug. Moreover, the onset of the glass transition was slightly shifted to lower temperatures when the drug was loaded in unmodified MSNs, and MSNs modified with APTES composite, while it increased in the case of TMPS-modified MSNs. Dielectric studies have confirmed these changes and allowed researchers to disclose the broad glass transition in multiple relaxations associated with different FNB populations. Moreover, DRS showed relaxation processes in dehydrated composites associated with surface-anchored FNB molecules whose mobility showed a correlation with the observed drug release profiles.
format Online
Article
Text
id pubmed-10301214
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103012142023-06-29 Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles Figari, Giorgia Gonçalves, José L. M. Diogo, Hermínio P. Dionísio, Madalena Farinha, José Paulo Viciosa, María Teresa Pharmaceutics Article To investigate the impact of the surface functionalization of mesoporous silica nanoparticle (MSN) carriers in the physical state, molecular mobility and the release of Fenofibrate (FNB) MSNs with ordered cylindrical pores were prepared. The surface of the MSNs was modified with either (3-aminopropyl) triethoxysilane (APTES) or trimethoxy(phenyl)silane (TMPS), and the density of the grafted functional groups was quantified via (1)H-NMR. The incorporation in the ~3 nm pores of the MSNs promoted FNB amorphization, as evidenced via FTIR, DSC and dielectric analysis, showing no tendency to undergo recrystallization in opposition to the neat drug. Moreover, the onset of the glass transition was slightly shifted to lower temperatures when the drug was loaded in unmodified MSNs, and MSNs modified with APTES composite, while it increased in the case of TMPS-modified MSNs. Dielectric studies have confirmed these changes and allowed researchers to disclose the broad glass transition in multiple relaxations associated with different FNB populations. Moreover, DRS showed relaxation processes in dehydrated composites associated with surface-anchored FNB molecules whose mobility showed a correlation with the observed drug release profiles. MDPI 2023-05-30 /pmc/articles/PMC10301214/ /pubmed/37376073 http://dx.doi.org/10.3390/pharmaceutics15061624 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Figari, Giorgia
Gonçalves, José L. M.
Diogo, Hermínio P.
Dionísio, Madalena
Farinha, José Paulo
Viciosa, María Teresa
Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles
title Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles
title_full Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles
title_fullStr Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles
title_full_unstemmed Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles
title_short Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles
title_sort understanding fenofibrate release from bare and modified mesoporous silica nanoparticles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301214/
https://www.ncbi.nlm.nih.gov/pubmed/37376073
http://dx.doi.org/10.3390/pharmaceutics15061624
work_keys_str_mv AT figarigiorgia understandingfenofibratereleasefrombareandmodifiedmesoporoussilicananoparticles
AT goncalvesjoselm understandingfenofibratereleasefrombareandmodifiedmesoporoussilicananoparticles
AT diogoherminiop understandingfenofibratereleasefrombareandmodifiedmesoporoussilicananoparticles
AT dionisiomadalena understandingfenofibratereleasefrombareandmodifiedmesoporoussilicananoparticles
AT farinhajosepaulo understandingfenofibratereleasefrombareandmodifiedmesoporoussilicananoparticles
AT viciosamariateresa understandingfenofibratereleasefrombareandmodifiedmesoporoussilicananoparticles